Efficacy of Transversus Abdominis Plane Block
1 other identifier
interventional
106
1 country
2
Brief Summary
This study aims to assess the efficacy of Transversus Abdominus Plane (TAP) blocks, a well-established anesthetic technique, to decrease the amount of post-operative pain in patients who undergo minimally invasive gynecologic surgeries. During minimally invasive gynecologic surgeries, the abdomen is inflated with pressurized air for visualization purposes and released at the end of the surgery. Traditionally, TAP blocks are performed by injecting long-acting local anesthetic agents under ultrasound guidance into the abdominal wall after abdominal surgery after the air has been emptied from the abdomen for additional anesthetic coverage post-operatively. This study proposes a novel approach: that performing TAP blocks while the abdomen is still insufflated will result in better post-operative pain outcomes as compared to the traditional method.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 22, 2023
CompletedFirst Submitted
Initial submission to the registry
February 13, 2024
CompletedFirst Posted
Study publicly available on registry
February 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedMarch 24, 2025
March 1, 2025
1.5 years
February 13, 2024
March 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Time to perform TAP Block
Time taken to successfully perform the TAP block. Defined as the time from initial placement of ultrasound probe on the skin to the completion of the block on the contralateral side.
Within 10 minutes of starting procedure.
TAP block attempts
The number of attempts taken to sucessfully perform the TAP block.
Within 10 minutes of starting procedure.
Pain Score Visual Analog Scale (VAS) 0 Hours Post Surgery
Pain score on an 11-point (0 - no pain to 10 - worst imaginable pain) Visual Analog Scale (VAS) at rest
0 hours following TAP block]
Pain Score Visual Analog Scale (VAS) 1 Hours Post Surgery
Pain score on an 11-point (0 - no pain to 10 - worst imaginable pain) Visual Analog Scale (VAS) at rest
1 hour following TAP block]
Pain Score Visual Analog Scale (VAS) 2 Hours Post Surgery
Pain score on an 11-point (0 - no pain to 10 - worst imaginable pain) Visual Analog Scale (VAS) at rest
2 hours following TAP block]
Pain Score Visual Analog Scale (VAS) 4 Hours Post Surgery
Pain score on an 11-point (0 - no pain to 10 - worst imaginable pain) Visual Analog Scale (VAS) at rest
4 hours following TAP block]
Pain Score Visual Analog Scale (VAS) 24 Hours Post Surgery
Pain score on an 11-point (0 - no pain to 10 - worst imaginable pain) Visual Analog Scale (VAS) at rest
24 hours following TAP block]
Postoperative Opioid Consumption
Patient opioid consumption in the 24 hours post TAP block
24 hours post operative period
Ease of performing TAP Block-anatomical plane visualization
The anatomical planes were clearly visualized and identified. Survey of operator - Likert Score
Within 10 minutes of starting procedure
Ease of performing TAP Block-performance efficacy
The approach optimized the efficacy of the block. Survey of operator- Likert score
Within 10 minutes of starting procedure
Patient satisfaction
Patient satisfaction with analgesia score (0 to 100%)
24-hours post operative period
Study Arms (2)
Active Comparator: Transversus abdominis plane (TAP) block performed in operating room
ACTIVE COMPARATORThe treatment group will have a transversus abdominis plane (TAP) block performed prior to closing surgical port sites post-operatively in an insufflated abdomen in the operating room (OR). The local anesthetic used for the TAP block will be 30 to 40ml of Ropivacaine 0.375%, not to exceed a max dose of 3mg/kg of 0.375% divided equally bilaterally. Each study participant will receive standard post-operative pain medication orders of morphine 2mg q5mins times 4 doses followed by hydromorphone. 0.5mg q10mins times 4 doses.
Transversus abdominis plane (TAP) block performed in PACU
ACTIVE COMPARATORThe treatment group will have a transversus abdominis plane (TAP) block performed post-operatively after the patient has been transferred from the Operating Room to the Post Anesthesia Care Unit (PACU). The local anesthetic used for the TAP block will be 30 to 40ml of Ropivacaine 0.375%, not to exceed a max dose of 3mg/kg of 0.375% divided equally bilaterally. Each study participant will receive standard post-operative pain medication orders of morphine 2mg q5mins times 4 doses followed by hydromorphone. 0.5mg q10mins times 4 doses
Interventions
A transversus abdominis plane block (TAP) block using a long-acting local anesthetic is used to manage pain during the intermediate (12-24hr) post-operative period following laparoscopic abdominal surgeries. Drug: The local anesthetic to be used in this specific intervention will be 30 to 40ml of Ropivacaine 0.375%, not to exceed a max dose of 3mg/kg of 0.375% and divided equally bilaterally.
Eligibility Criteria
You may qualify if:
- Female gynecological patients between 18 years and 85 years consented and scheduled for an obstetrics/gynecology laparoscopic procedure.
- Consent received to receive a TAP block.
You may not qualify if:
- Patients who are not proficient in the English language or cannot consent
- Patients who have an allergy to local anesthetics (amides)
- Patients with subcutaneous emphysema
- Patients whose surgical procedures require incisions above the umbilicus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Justin Hruskalead
Study Sites (2)
Detroit Medical Center Detroit Receiving Hospital
Detroit, Michigan, 48201, United States
Detroit Medical Center, Harper University Hospital
Detroit, Michigan, 48201, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Justin Hruska, MD
Wayne State University/Detroit Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The patient will be unaware of their grouping allotment. The outcomes assessor will be unaware of the patient grouping allotment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 13, 2024
First Posted
February 23, 2024
Study Start
June 22, 2023
Primary Completion
January 1, 2025
Study Completion
March 1, 2025
Last Updated
March 24, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share